Generic placeholder image

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders

Author(s): Philippe Taupin

Volume 11, Issue 1, 2011

Page: [35 - 37] Pages: 3

DOI: 10.2174/187152411794961103

Price: $65

Abstract

Neurological diseases and related conditions affect an estimated 1 billion of individuals worldwide [1]. There is still no cure for neurological diseases and disorders, barely a few treatments more or less efficient. This mandates the design and development of novel paradigms and strategies, to discover and develop new treatments and cures for these diseases. Neurogenesis occurs in the adult brain of mammals primarily in two regions, the dentate gyrus (DG) of the hippocampus and the subventricular zone, in various species including in humans. Neural progenitor and stem cells have been isolated, propagated and characterized in vitro from the adult brain of mammals, including humans. The confirmation that neurogenesis occurs in the adult brain and neural stem cells (NSCs) reside in the adult central nervous system (CNS) of mammals, opens new avenues and opportunities for treating neurological diseases and injuries [2].

Keywords: Alzheimer disease, depression, drug, hippocampus, neurogenic, neurogenesis, pharmacology, regeneration, therapy, neural stem cells, neurological diseases, nervous system, mossy fiber, granule cells, learning and memory, epilepsy, neurodegenerative disease, animal model, pathology, physiology, memantine, fluoxetine, apigenin, glutamate agonist, piracetam


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy